|
|
||||||||
Journal of Lipid Research, Vol. 9, 602-605, September 1968
Copyright © 1968 by Lipid Research, Inc.
Departments of Metabolic Research and Pharmacology, The Upjohn Company, Kalamazoo, Michigan 49001
Infusion of 1 mg/kg per day of prostaglandin E1 (PGE1) for 2 and 7 wk failed to correct the dermal signs of essential fatty acid (EFA) deficiency in rats despite the known conversion of EFA to certain prostaglandins. PGE1 caused no significant changes in serum cholesterol, triglycerides, or phospholipids or in liver neutral lipids in EFA-deficient or normal rats. In normal rats epinephrine-induced lipolysis was greater in fat pads from infused than from untreated rats. The effect on epinephrine-induced lipolysis was greater after the 7 wk infusion than after the 2 wk infusion. The 7 wk infusion also lowered plasma free fatty acid (FFA) concentrations. Infusion of PGE2 and PGF2
in combination for 4 wk had no significant effect on either dermal signs of EFA deficiency, lipolysis, or plasma FFA concentrations.
Supplementary key words prostaglandin E1 E2 F2
essential fatty acid deficiency lipolysis plasma free fatty acids
Submitted on March 28, 1968
Accepted on May 27, 1968
This article has been cited by other articles:
![]() |
K. Wallis, E. Azizi, A.J. Kook, E. Herczeg, A. Julsary, A. Szeinberg, and J.L. Zaidman Acrodermatitis Enteropathica Associated with Low Density Lipoproteins Deficiency Clinical Pediatrics, September 1, 1974; 13(9): 749 - 754. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |